349 related articles for article (PubMed ID: 14677630)
1. Determination of conditions for the production scale sterilization of prefilled syringes.
Nishimoto N; Maekawa T
PDA J Pharm Sci Technol; 2003; 57(5):378-86. PubMed ID: 14677630
[TBL] [Abstract][Full Text] [Related]
2. Non-destructive vacuum decay method for pre-filled syringe closure integrity testing compared with dye ingress testing and high-voltage leak detection.
Simonetti A; Amari F
PDA J Pharm Sci Technol; 2015; 69(1):108-22. PubMed ID: 25691719
[TBL] [Abstract][Full Text] [Related]
3. Low Leachable Container System Consisting of a Polymer-Based Syringe with Chlorinated Isoprene Isobutene Rubber Plunger Stopper.
Kiminami H; Takeuchi K; Nakamura K; Abe Y; Lauwers P; Dierick W; Yoshino K; Suzuki S
PDA J Pharm Sci Technol; 2015; 69(6):713-24. PubMed ID: 26659102
[TBL] [Abstract][Full Text] [Related]
4. Microbial contamination potential of solutions in prefilled disposable syringes used with a syringe pump.
Mitrano FP; Baptista RJ; Newton DW; Augustine SC
Am J Hosp Pharm; 1986 Jan; 43(1):78-80. PubMed ID: 3953587
[TBL] [Abstract][Full Text] [Related]
5. Stopper Movement and Headspace (Air Bubble Size) Limitations for 2.25 mL Prefilled Syringe.
Evans C; Oni Y; Paniagua D; Franck J; Dahlheim C; Kulshrestha A
PDA J Pharm Sci Technol; 2023 Dec; 77(6):472-484. PubMed ID: 37580129
[TBL] [Abstract][Full Text] [Related]
6. Microbial contamination potential of sterile disposable plastic syringes.
Huey WY; Newton DW; Augustine SC; Vejraska BD; Mitrano FP
Am J Hosp Pharm; 1985 Jan; 42(1):102-5. PubMed ID: 3918439
[TBL] [Abstract][Full Text] [Related]
7. Impact of Drug Formulation Variables on Silicone Oil Structure and Functionality of Prefilled Syringe System.
Shi GH; Gopalrathnam G; Shinkle SL; Dong X; Hofer JD; Jensen EC; Rajagopalan N
PDA J Pharm Sci Technol; 2018; 72(1):50-61. PubMed ID: 29030531
[TBL] [Abstract][Full Text] [Related]
8. Risk Mitigation of Plunger-Stopper Displacement Under Low Atmospheric Pressure by Establishing Design Space for Filling-Stoppering Process of Prefilled Syringes: A Design of Experiment (DoE) Approach.
Mehta SB; Cook J; Liu W; Brisbane C
J Pharm Sci; 2022 Jul; 111(7):2038-2048. PubMed ID: 35122830
[TBL] [Abstract][Full Text] [Related]
9. Multiple withdrawals from single-use vials: a study on sterility.
Ripoll Gallardo A; Meneghetti G; Ragazzoni L; Kroumova V; Ferrante D; Ingrassia PL; Ruzza P; Dell'Era A; Boniolo E; Koraqe G; Faggiano F; Della Corte F
Int J Pharm; 2015 May; 485(1-2):160-3. PubMed ID: 25769293
[TBL] [Abstract][Full Text] [Related]
10. Consequence of syringe-plunger contamination.
Perceval A
Med J Aust; 1980 May; 1(10):487-9. PubMed ID: 7412683
[TBL] [Abstract][Full Text] [Related]
11. Safety, effectiveness and ease of use of a non-reusable syringe in a developing country immunization programme.
Steinglass R; Boyd D; Grabowsky M; Laghari AG; Khan MA; Qavi A; Evans P
Bull World Health Organ; 1995; 73(1):57-63. PubMed ID: 7704926
[TBL] [Abstract][Full Text] [Related]
12. Maintenance of sterility in 1-mL polypropylene syringes.
Gonzalez S; Miller D; Murphy SP
Am J Health Syst Pharm; 2007 Sep; 64(18):1962-4. PubMed ID: 17823109
[TBL] [Abstract][Full Text] [Related]
13. Syringe plunger contamination by hazardous drugs: a comparative study.
Smith ST; Szlaczky MC
J Oncol Pharm Pract; 2014 Oct; 20(5):381-5. PubMed ID: 24598373
[TBL] [Abstract][Full Text] [Related]
14. A strategy for the prevention of protein oxidation by drug product in polymer-based syringes.
Nakamura K; Abe Y; Kiminami H; Yamashita A; Iwasaki K; Suzuki S; Yoshino K; Dierick W; Constable K
PDA J Pharm Sci Technol; 2015; 69(1):88-95. PubMed ID: 25691717
[TBL] [Abstract][Full Text] [Related]
15. Long-term sterility of syringes filled robotically from vials.
Tribble DA
Am J Health Syst Pharm; 2007 May; 64(9):926, 928. PubMed ID: 17468145
[No Abstract] [Full Text] [Related]
16. Sterility of insulin in prefilled disposable syringes.
Jackson EA; Gallo BM
Am J Hosp Pharm; 1990 Nov; 47(11):2508-10. PubMed ID: 2278263
[TBL] [Abstract][Full Text] [Related]
17. Filling vials aseptically while monitoring for bacterial contamination.
Dirksen JW; Larsen RV
Am J Hosp Pharm; 1975 Oct; 32(10):1031-2. PubMed ID: 1190216
[TBL] [Abstract][Full Text] [Related]
18. The stability and sterility of epinephrine prefilled syringe.
Kerddonfak S; Manuyakorn W; Kamchaisatian W; Sasisakulporn C; Teawsomboonkit W; Benjaponpitak S
Asian Pac J Allergy Immunol; 2010 Mar; 28(1):53-7. PubMed ID: 20527517
[TBL] [Abstract][Full Text] [Related]
19. CONTAMINATION OF ANTI-VEGF DRUGS FOR INTRAVITREAL INJECTION: How Do Repackaging and Newly Developed Syringes Affect the Amount of Silicone Oil Droplets and Protein Aggregates?
Schargus M; Werner BP; Geerling G; Winter G
Retina; 2018 Oct; 38(10):2088-2095. PubMed ID: 28841584
[TBL] [Abstract][Full Text] [Related]
20. Microbial barrier assessment of Tyvek stopper packaging for rubber closures.
Moldenhauer JE; Bass SA; Kupinski MJ; Walters ML; Rubio SL
PDA J Pharm Sci Technol; 1996; 50(6):391-8. PubMed ID: 9038086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
